
Global Alcohol Addiction Therapeutics Market By Product Type (5-HT3 Receptor Antagonist, Antidotes, Others), By End User (Hospital Pharmacies, Retail Pharmacies, Rehabilitation Centers), and Region - Global Forecast to 2030
-
13208
-
April 2023
-
284
-
-
This report was compiled by Trishita Deb Trishita Deb is an experienced market research and consulting professional with over 7 years of expertise across healthcare, consumer goods, and materials, contributing to over 400 healthcare-related reports. Correspondence Team Lead- Healthcare Linkedin | Detailed Market research Methodology Our methodology involves a mix of primary research, including interviews with leading mental health experts, and secondary research from reputable medical journals and databases. View Detailed Methodology Page
-
“Global Alcohol Addiction Therapeutics Market” is the title of recently published market report compiled by MarketResearch.Biz. The report contains information and data, and inputs from both primary and secondary data sources, that have been verified and validated by experts in the target market. The report presents a thorough study of revenues, historical data, and information, key developments, and strategies by major players that offer vital insights and perspectives in to various scenarios market. Besides critical data and related information, the report includes key trends (both present and future), factors that are driving market growth, factors that are or could be potential restraints to market growth, as well as opportunities that can be leveraged for potential revenue generation in untapped regions and countries. It also covers threats or challenges for existing as well as new entrants in the market. The global alcohol addiction therapeutics market has been segmented on the basis of product type, end-user, as well as regions and countries.
The Global Alcohol Addiction Therapeutics Market was valued at UЅD $884 Мn in 2020, and is projected to achieve a valuation of UЅD $1,498.3 Мn by 2030, at a САGR of 6.5%.
Overview:
Alcohol addiction therapeutics refers to the various forms of treatment options that are given to individuals who suffer from Alcohol Use Disorder (AUD), including detoxification, behavior modification, counseling and medication.
Dynamics:
The growing awareness among individuals concerning the numerous disadvantages to the excessive consumption of alcohol such as liver inflammation, high, blood, pressure, the development of a host of cancers like stomach, liver, colon, breast, and mouth, is a primary factor that is expected to continue to fuel the revenue growth of the global alcohol addiction therapeutics market over the next 10 years.
Moreover, the exponential increase in the number of alcohol-related deaths, especially in recent years, is another primary factor that is slated to play a pivotal role in boosting the demand for alcohol addiction therapeutic products, thereby significantly influencing future market growth opportunities in the process.
However, in light of the recent COVID-19 outbreak, the operations of numerous industries have either been temporarily halted or are functioning with a minimal workforce due to enforced lockdowns and imposed restrictions by respective governing bodies. The global alcohol addiction therapeutics market is no different, and is a factor that is expected to have a significantly negative impact on the revenue growth of this industry in the coming years.
Additionally, the ease in the availability of alcohol across the globe, and the lax enforcement of adequate regulations to prevent its abuse are some other factors that are expected to have a negative impact on the market growth of this global industry in the near future.
Nonetheless, numerous initiatives being undertaken by key market players as well as governing bodies to improving access to alcohol addiction therapeutics, and to increase awareness levels concerning the benefits of responsible alcohol consumption are also other factors that are anticipated to positively influence market growth prospects for the global alcohol addiction therapeutics market in the foreseeable future.
Segmentation of the global alcohol addiction therapeutics market is as follows:
In terms of type, the others segment accounted for the maximum number of revenue shares of the global alcohol addiction therapeutics market in 2020, and is expected to continue doing so over the forecast period. The 5-HT3 receptor antagonist segment is also anticipated to register a considerable CAGR over the next 10 years.
With regards to end-user, the hospital pharmacies segment accounted for the highest number of revenue shares of the global alcohol addiction therapeutics market in 2020. The retail pharmacies segment is also expected to register considerable revenue growth in the years to come.
Regional Segmentation and Analysis:
North America accounted for the maximum number of revenue shares of the global alcohol addiction therapies market in 2020, and is expected to index a high CAGR over the remainder of this forecast period. However, the markets in the Asia Pacific region are anticipated to register the highest CAGR over the next 10 years.
Segmentation of the Global Alcohol Addiction Therapeutics Market:
Segmentation by Product Type:
- 5-HT3 Receptor Antagonist
- Antidotes
- Others
Segmentation by End-User:
- Hospital Pharmacies
- Retail Pharmacies
- Rehabilitation Centers
- Other End-Users
Segmentation by Regions:
- North America
- Europe
- APAC
- South America
- MEA
Attribute Report Details Market Size Ask For Market Size Growth Rate Ask For Growth Rate Key Companies Ask For Companies Report Coverage Revenue analysis, Competitive landscape, Key company analysis, Market Trends, Key segments, Distribution Channel, Market Dynamics, COVID-19 Impact Analysis and more… Historical Data Period 2015-2020 Base Year 2022 Forecast Period 2022-2031 Region Scope North America, Europe, Asia-Pacific, South America, Middle East & Africa Country Scope United States, Canada and Mexico, Germany, France, UK, Russia and Italy, China, Japan, Korea, India and Southeast Asia, Brazil, Argentina, Colombia etc.Saudi Arabia, UAE, Egypt, Nigeria and South Africa Revenue in US$ Mn -
- Chapter 1 Global Alcohol Addiction Therapeutics Market Insights
- 1.1 Introduction
- 1.2 Segmentation for Global Alcohol Addiction Therapeutics Market, based on Product Type, Application, and Region
- 1.3 Drivers for Global Alcohol Addiction Therapeutics Market
- 1.4 Restraints for Global Alcohol Addiction Therapeutics Market
- 1.5 Opportunities for Global Alcohol Addiction Therapeutics Market
- 1.6 Trends for Global Alcohol Addiction Therapeutics Market
- 1.7 Macro-economic Factors
- 1.8 Opportunity Map Analysis
- 1.8.1 Optimistic Scenario
- 1.8.2 Likely Scenario
- 1.8.3 Conservative Scenario
- 1.9 Opportunity Orbits
- 1.10 Market Investment Feasibility Index
- 1.11 PEST Analysis
- 1.12 PORTER’s Five Forces Analysis
- 1.13 Regional Market Share and BPS Analysis
- 1.14 Alcohol Consumption
- 1.14.1 Alcohol Consumption Over Long Term
- 1.14.2 Alcohol consumption across the world today
- 1.14.3 Heavy drinking sessions
- 1.14.4 Most Consumed Alcoholic Beverages
- 1.14.5 Alcohol Use Disorders
- 1.14.6 Alcohol Use Treatment
- Chapter 2 Global Alcohol Addiction Therapeutics Market Overview
- 2.1 Global Alcohol Addiction Therapeutics Market by Type
- 2.1.1 Global Alcohol Addiction Therapeutics Revenue (US$ Mn) Comparison by Type (2013-2029)
- 2.1.2 Global Alcohol Addiction Therapeutics Revenue (US$ Mn) Market Share by Type in 2019
- 2.1.3 Global Alcohol Addiction Therapeutics Market Attractiveness Analysis by Type, 2013–2019
- 2.2 Global Alcohol Addiction Therapeutics Market by End User
- 2.2.1 Global Alcohol Addiction Therapeutics Revenue (US$ Mn) Comparison by End User (2013-2029)
- 2.2.2 Global Alcohol Addiction Therapeutics Revenue (US$ Mn) Market Share by End User in 2019
- 2.2.3 Global Alcohol Addiction Therapeutics Market Attractiveness Analysis by End User, 2013–2019
- 2.3 Global Alcohol Addiction Therapeutics Market Outlook by Region
- 2.3.1 Global Alcohol Addiction Therapeutics Revenue (US$ Mn) Comparison by Region (2013-2029)
- 2.3.2 Global Alcohol Addiction Therapeutics Revenue (US$ Mn) Market Share by Region in 2018
- 2.3.3 Global Alcohol Addiction Therapeutics Market Attractiveness Analysis by Region, 2012–2018
- 2.4 Global Alcohol Addiction Therapeutics Market Outlook (2013-2029)
- 2.4.1 Global Alcohol Addiction Therapeutics Revenue (US$ Mn) (2013-2020)
- 2.4.2 Global Alcohol Addiction Therapeutics Revenue (US$ Mn) (2021-2029)
- 2.5 Global Alcohol Addiction Therapeutics Revenue (US$ Mn) by Regions
- 2.5.1 Global Alcohol Addiction Therapeutics Revenue (US$ Mn) Comparison by Region (2013-2020)
- 2.5.2 Global Alcohol Addiction Therapeutics Revenue (US$ Mn) Comparison by Region (2021-2029)
- 2.6 Global Alcohol Addiction Therapeutics Revenue (US$ Mn) by Type
- 2.6.1 Global Alcohol Addiction Therapeutics Revenue (US$ Mn) Comparison by Type (2013-2020)
- 2.6.2 Global Alcohol Addiction Therapeutics Revenue (US$ Mn) Comparison by Type (2021-2029)
- 2.7 Global Alcohol Addiction Therapeutics Revenue (US$ Mn) by End User
- 2.7.1 Global Alcohol Addiction Therapeutics Revenue (US$ Mn) Comparison by End User (2013-2020)
- 2.7.2 Global Alcohol Addiction Therapeutics Revenue (US$ Mn) Comparison by End User (2021-2029)
- 2.8 Global Alcohol Addiction Therapeutics Y-o-Y Growth Rate Comparison 2014–2029
- 2.8.1 Global Alcohol Addiction Therapeutics Y-o-Y Growth Rate by Region
- 2.8.2 Global Alcohol Addiction Therapeutics Market Y-o-Y Growth Rate by Type
- 2.8.3 Global Alcohol Addiction Therapeutics Y-o-Y Growth Rate by End User
- 2.9 Global Alcohol Addiction Therapeutics Share Comparison 2014–2029
- 2.9.1 Global Alcohol Addiction Therapeutics Share by Region
- 2.9.2 Global Alcohol Addiction Therapeutics Market Share by Type
- 2.9.3 Global Alcohol Addiction Therapeutics Share by End User
- 2.1 Global Alcohol Addiction Therapeutics Market by Type
- Chapter 3 North America Alcohol Addiction Therapeutics Market Overview
- 3.1 North America Alcohol Addiction Therapeutics Market by Type
- 3.1.1 North America Alcohol Addiction Therapeutics Revenue (US$ Mn) Comparison by Type (2013-2029)
- 3.1.2 North America Alcohol Addiction Therapeutics Revenue (US$ Mn) Market Share by Type in 2019
- 3.1.3 North America Alcohol Addiction Therapeutics Market Attractiveness Analysis by Type, 2013–2019
- 3.2 North America Alcohol Addiction Therapeutics Market by End User
- 3.2.1 North America Alcohol Addiction Therapeutics Revenue (US$ Mn) Comparison by End User (2013-2029)
- 3.2.2 North America Alcohol Addiction Therapeutics Revenue (US$ Mn) Market Share by End User in 2019
- 3.2.3 North America Alcohol Addiction Therapeutics Market Attractiveness Analysis by End User, 2013–2019
- 3.3 North America Alcohol Addiction Therapeutics Market Outlook by Region
- 3.3.1 North America Alcohol Addiction Therapeutics Revenue (US$ Mn) Comparison by Region (2013-2029)
- 3.3.2 North America Alcohol Addiction Therapeutics Revenue (US$ Mn) Market Share by Region in 2018
- 3.3.3 North America Alcohol Addiction Therapeutics Market Attractiveness Analysis by Region, 2012–2018
- 3.4 North America Alcohol Addiction Therapeutics Market Outlook (2013-2029)
- 3.4.1 North America Alcohol Addiction Therapeutics Revenue (US$ Mn) (2013-2020)
- 3.4.2 North America Alcohol Addiction Therapeutics Revenue (US$ Mn) (2021-2029)
- 3.5 North America Alcohol Addiction Therapeutics Revenue (US$ Mn) by Regions
- 3.5.1 North America Alcohol Addiction Therapeutics Revenue (US$ Mn) Comparison by Region (2013-2020)
- 3.5.2 North America Alcohol Addiction Therapeutics Revenue (US$ Mn) Comparison by Region (2021-2029)
- 3.6 North America Alcohol Addiction Therapeutics Revenue (US$ Mn) by Type
- 3.6.1 North America Alcohol Addiction Therapeutics Revenue (US$ Mn) Comparison by Type (2013-2020)
- 3.6.2 North America Alcohol Addiction Therapeutics Revenue (US$ Mn) Comparison by Type (2021-2029)
- 3.7 North America Alcohol Addiction Therapeutics Revenue (US$ Mn) by End User
- 3.7.1 North America Alcohol Addiction Therapeutics Revenue (US$ Mn) Comparison by End User (2013-2020)
- 3.7.2 North America Alcohol Addiction Therapeutics Revenue (US$ Mn) Comparison by End User (2021-2029)
- 3.8 North America Alcohol Addiction Therapeutics Y-o-Y Growth Rate Comparison 2014–2029
- 3.8.1 North America Alcohol Addiction Therapeutics Y-o-Y Growth Rate by Region
- 3.8.2 North America Alcohol Addiction Therapeutics Market Y-o-Y Growth Rate by Type
- 3.8.3 North America Alcohol Addiction Therapeutics Y-o-Y Growth Rate by End User
- 3.9 North America Alcohol Addiction Therapeutics Share Comparison 2014–2029
- 3.9.1 North America Alcohol Addiction Therapeutics Share by Region
- 3.9.2 North America Alcohol Addiction Therapeutics Market Share by Type
- 3.9.3 North America Alcohol Addiction Therapeutics Share by End User
- 3.1 North America Alcohol Addiction Therapeutics Market by Type
- Chapter 4 Europe Alcohol Addiction Therapeutics Market Overview
- 4.1 Europe Alcohol Addiction Therapeutics Market by Type
- 4.1.1 Europe Alcohol Addiction Therapeutics Revenue (US$ Mn) Comparison by Type (2013-2029)
- 4.1.2 Europe Alcohol Addiction Therapeutics Revenue (US$ Mn) Market Share by Type in 2019
- 4.1.3 Europe Alcohol Addiction Therapeutics Market Attractiveness Analysis by Type, 2013–2019
- 4.2 Europe Alcohol Addiction Therapeutics Market by End User
- 4.2.1 Europe Alcohol Addiction Therapeutics Revenue (US$ Mn) Comparison by End User (2013-2029)
- 4.2.2 Europe Alcohol Addiction Therapeutics Revenue (US$ Mn) Market Share by End User in 2019
- 4.2.3 Europe Alcohol Addiction Therapeutics Market Attractiveness Analysis by End User, 2013–2019
- 4.3 Europe Alcohol Addiction Therapeutics Market Outlook by Region
- 4.3.1 Europe Alcohol Addiction Therapeutics Revenue (US$ Mn) Comparison by Region (2013-2029)
- 4.3.2 Europe Alcohol Addiction Therapeutics Revenue (US$ Mn) Market Share by Region in 2018
- 4.3.3 Europe Alcohol Addiction Therapeutics Market Attractiveness Analysis by Region, 2012–2018
- 4.4 Europe Alcohol Addiction Therapeutics Market Outlook (2013-2029)
- 4.4.1 Europe Alcohol Addiction Therapeutics Revenue (US$ Mn) (2013-2020)
- 4.4.2 Europe Alcohol Addiction Therapeutics Revenue (US$ Mn) (2021-2029)
- 4.5 Europe Alcohol Addiction Therapeutics Revenue (US$ Mn) by Regions
- 4.5.1 Europe Alcohol Addiction Therapeutics Revenue (US$ Mn) Comparison by Region (2013-2020)
- 4.5.2 Europe Alcohol Addiction Therapeutics Revenue (US$ Mn) Comparison by Region (2021-2029)
- 4.6 Europe Alcohol Addiction Therapeutics Revenue (US$ Mn) by Type
- 4.6.1 Europe Alcohol Addiction Therapeutics Revenue (US$ Mn) Comparison by Type (2013-2020)
- 4.6.2 Europe Alcohol Addiction Therapeutics Revenue (US$ Mn) Comparison by Type (2021-2029)
- 4.7 Europe Alcohol Addiction Therapeutics Revenue (US$ Mn) by End User
- 4.7.1 Europe Alcohol Addiction Therapeutics Revenue (US$ Mn) Comparison by End User (2013-2020)
- 4.7.2 Europe Alcohol Addiction Therapeutics Revenue (US$ Mn) Comparison by End User (2021-2029)
- 4.8 Europe Alcohol Addiction Therapeutics Y-o-Y Growth Rate Comparison 2014–2029
- 4.8.1 Europe Alcohol Addiction Therapeutics Y-o-Y Growth Rate by Region
- 4.8.2 Europe Alcohol Addiction Therapeutics Market Y-o-Y Growth Rate by Type
- 4.8.3 Europe Alcohol Addiction Therapeutics Y-o-Y Growth Rate by End User
- 4.9 Europe Alcohol Addiction Therapeutics Share Comparison 2014–2029
- 4.9.1 Europe Alcohol Addiction Therapeutics Share by Region
- 4.9.2 Europe Alcohol Addiction Therapeutics Market Share by Type
- 4.9.3 Europe Alcohol Addiction Therapeutics Share by End User
- 4.1 Europe Alcohol Addiction Therapeutics Market by Type
- Chapter 5 APAC Alcohol Addiction Therapeutics Market Overview
- 5.1 APAC Alcohol Addiction Therapeutics Market by Type
- 5.1.1 APAC Alcohol Addiction Therapeutics Revenue (US$ Mn) Comparison by Type (2013-2029)
- 5.1.2 APAC Alcohol Addiction Therapeutics Revenue (US$ Mn) Market Share by Type in 2019
- 5.1.3 APAC Alcohol Addiction Therapeutics Market Attractiveness Analysis by Type, 2013–2019
- 5.2 APAC Alcohol Addiction Therapeutics Market by End User
- 5.2.1 APAC Alcohol Addiction Therapeutics Revenue (US$ Mn) Comparison by End User (2013-2029)
- 5.2.2 APAC Alcohol Addiction Therapeutics Revenue (US$ Mn) Market Share by End User in 2019
- 5.2.3 APAC Alcohol Addiction Therapeutics Market Attractiveness Analysis by End User, 2013–2019
- 5.3 APAC Alcohol Addiction Therapeutics Market Outlook by Region
- 5.3.1 APAC Alcohol Addiction Therapeutics Revenue (US$ Mn) Comparison by Region (2013-2029)
- 5.3.2 APAC Alcohol Addiction Therapeutics Revenue (US$ Mn) Market Share by Region in 2018
- 5.3.3 APAC Alcohol Addiction Therapeutics Market Attractiveness Analysis by Region, 2012–2018
- 5.4 APAC Alcohol Addiction Therapeutics Market Outlook (2013-2029)
- 5.4.1 APAC Alcohol Addiction Therapeutics Revenue (US$ Mn) (2013-2020)
- 5.4.2 APAC Alcohol Addiction Therapeutics Revenue (US$ Mn) (2021-2029)
- 5.5 APAC Alcohol Addiction Therapeutics Revenue (US$ Mn) by Regions
- 5.5.1 APAC Alcohol Addiction Therapeutics Revenue (US$ Mn) Comparison by Region (2013-2020)
- 5.5.2 APAC Alcohol Addiction Therapeutics Revenue (US$ Mn) Comparison by Region (2021-2029)
- 5.6 APAC Alcohol Addiction Therapeutics Revenue (US$ Mn) by Type
- 5.6.1 APAC Alcohol Addiction Therapeutics Revenue (US$ Mn) Comparison by Type (2013-2020)
- 5.6.2 APAC Alcohol Addiction Therapeutics Revenue (US$ Mn) Comparison by Type (2021-2029)
- 5.7 APAC Alcohol Addiction Therapeutics Revenue (US$ Mn) by End User
- 5.7.1 APAC Alcohol Addiction Therapeutics Revenue (US$ Mn) Comparison by End User (2013-2020)
- 5.7.2 APAC Alcohol Addiction Therapeutics Revenue (US$ Mn) Comparison by End User (2021-2029)
- 5.8 APAC Alcohol Addiction Therapeutics Y-o-Y Growth Rate Comparison 2014–2029
- 5.8.1 APAC Alcohol Addiction Therapeutics Y-o-Y Growth Rate by Region
- 5.8.2 APAC Alcohol Addiction Therapeutics Market Y-o-Y Growth Rate by Type
- 5.8.3 APAC Alcohol Addiction Therapeutics Y-o-Y Growth Rate by End User
- 5.9 APAC Alcohol Addiction Therapeutics Share Comparison 2014–2029
- 5.9.1 APAC Alcohol Addiction Therapeutics Share by Region
- 5.9.2 APAC Alcohol Addiction Therapeutics Market Share by Type
- 5.9.3 APAC Alcohol Addiction Therapeutics Share by End User
- 5.1 APAC Alcohol Addiction Therapeutics Market by Type
- Chapter 6 South America Alcohol Addiction Therapeutics Market Overview
- 6.1 South America Alcohol Addiction Therapeutics Market by Type
- 6.1.1 South America Alcohol Addiction Therapeutics Revenue (US$ Mn) Comparison by Type (2013-2029)
- 6.1.2 South America Alcohol Addiction Therapeutics Revenue (US$ Mn) Market Share by Type in 2019
- 6.1.3 South America Alcohol Addiction Therapeutics Market Attractiveness Analysis by Type, 2013–2019
- 6.2 South America Alcohol Addiction Therapeutics Market by End User
- 6.2.1 South America Alcohol Addiction Therapeutics Revenue (US$ Mn) Comparison by End User (2013-2029)
- 6.2.2 South America Alcohol Addiction Therapeutics Revenue (US$ Mn) Market Share by End User in 2019
- 6.2.3 South America Alcohol Addiction Therapeutics Market Attractiveness Analysis by End User, 2013–2019
- 6.3 South America Alcohol Addiction Therapeutics Market Outlook by Region
- 6.3.1 South America Alcohol Addiction Therapeutics Revenue (US$ Mn) Comparison by Region (2013-2029)
- 6.3.2 South America Alcohol Addiction Therapeutics Revenue (US$ Mn) Market Share by Region in 2018
- 6.3.3 South America Alcohol Addiction Therapeutics Market Attractiveness Analysis by Region, 2012–2018
- 6.4 South America Alcohol Addiction Therapeutics Market Outlook (2013-2029)
- 6.4.1 South America Alcohol Addiction Therapeutics Revenue (US$ Mn) (2013-2020)
- 6.4.2 South America Alcohol Addiction Therapeutics Revenue (US$ Mn) (2021-2029)
- 6.5 South America Alcohol Addiction Therapeutics Revenue (US$ Mn) by Regions
- 6.5.1 South America Alcohol Addiction Therapeutics Revenue (US$ Mn) Comparison by Region (2013-2020)
- 6.5.2 South America Alcohol Addiction Therapeutics Revenue (US$ Mn) Comparison by Region (2021-2029)
- 6.6 South America Alcohol Addiction Therapeutics Revenue (US$ Mn) by Type
- 6.6.1 South America Alcohol Addiction Therapeutics Revenue (US$ Mn) Comparison by Type (2013-2020)
- 6.6.2 South America Alcohol Addiction Therapeutics Revenue (US$ Mn) Comparison by Type (2021-2029)
- 6.7 South America Alcohol Addiction Therapeutics Revenue (US$ Mn) by End User
- 6.7.1 South America Alcohol Addiction Therapeutics Revenue (US$ Mn) Comparison by End User (2013-2020)
- 6.7.2 South America Alcohol Addiction Therapeutics Revenue (US$ Mn) Comparison by End User (2021-2029)
- 6.8 South America Alcohol Addiction Therapeutics Y-o-Y Growth Rate Comparison 2014–2029
- 6.8.1 South America Alcohol Addiction Therapeutics Y-o-Y Growth Rate by Region
- 6.8.2 South America Alcohol Addiction Therapeutics Market Y-o-Y Growth Rate by Type
- 6.8.3 South America Alcohol Addiction Therapeutics Y-o-Y Growth Rate by End User
- 6.9 South America Alcohol Addiction Therapeutics Share Comparison 2014–2029
- 6.9.1 South America Alcohol Addiction Therapeutics Share by Region
- 6.9.2 South America Alcohol Addiction Therapeutics Market Share by Type
- 6.9.3 South America Alcohol Addiction Therapeutics Share by End User
- 6.1 South America Alcohol Addiction Therapeutics Market by Type
- Chapter 7 MEA Alcohol Addiction Therapeutics Market Overview
- 7.1 MEA Alcohol Addiction Therapeutics Market by Type
- 7.1.1 MEA Alcohol Addiction Therapeutics Revenue (US$ Mn) Comparison by Type (2013-2029)
- 7.1.2 MEA Alcohol Addiction Therapeutics Revenue (US$ Mn) Market Share by Type in 2019
- 7.1.3 MEA Alcohol Addiction Therapeutics Market Attractiveness Analysis by Type, 2013–2019
- 7.2 MEA Alcohol Addiction Therapeutics Market by End User
- 7.2.1 MEA Alcohol Addiction Therapeutics Revenue (US$ Mn) Comparison by End User (2013-2029)
- 7.2.2 MEA Alcohol Addiction Therapeutics Revenue (US$ Mn) Market Share by End User in 2019
- 7.2.3 MEA Alcohol Addiction Therapeutics Market Attractiveness Analysis by End User, 2013–2019
- 7.3 MEA Alcohol Addiction Therapeutics Market Outlook by Region
- 7.3.1 MEA Alcohol Addiction Therapeutics Revenue (US$ Mn) Comparison by Region (2013-2029)
- 7.3.2 MEA Alcohol Addiction Therapeutics Revenue (US$ Mn) Market Share by Region in 2018
- 7.3.3 MEA Alcohol Addiction Therapeutics Market Attractiveness Analysis by Region, 2012–2018
- 7.4 MEA Alcohol Addiction Therapeutics Market Outlook (2013-2029)
- 7.4.1 MEA Alcohol Addiction Therapeutics Revenue (US$ Mn) (2013-2020)
- 7.4.2 MEA Alcohol Addiction Therapeutics Revenue (US$ Mn) (2021-2029)
- 7.5 MEA Alcohol Addiction Therapeutics Revenue (US$ Mn) by Regions
- 7.5.1 MEA Alcohol Addiction Therapeutics Revenue (US$ Mn) Comparison by Region (2013-2020)
- 7.5.2 MEA Alcohol Addiction Therapeutics Revenue (US$ Mn) Comparison by Region (2021-2029)
- 7.6 MEA Alcohol Addiction Therapeutics Revenue (US$ Mn) by Type
- 7.6.1 MEA Alcohol Addiction Therapeutics Revenue (US$ Mn) Comparison by Type (2013-2020)
- 7.6.2 MEA Alcohol Addiction Therapeutics Revenue (US$ Mn) Comparison by Type (2021-2029)
- 7.7 MEA Alcohol Addiction Therapeutics Revenue (US$ Mn) by End User
- 7.7.1 MEA Alcohol Addiction Therapeutics Revenue (US$ Mn) Comparison by End User (2013-2020)
- 7.7.2 MEA Alcohol Addiction Therapeutics Revenue (US$ Mn) Comparison by End User (2021-2029)
- 7.8 MEA Alcohol Addiction Therapeutics Y-o-Y Growth Rate Comparison 2014–2029
- 7.8.1 MEA Alcohol Addiction Therapeutics Y-o-Y Growth Rate by Region
- 7.8.2 MEA Alcohol Addiction Therapeutics Market Y-o-Y Growth Rate by Type
- 7.8.3 MEA Alcohol Addiction Therapeutics Y-o-Y Growth Rate by End User
- 7.9 MEA Alcohol Addiction Therapeutics Share Comparison 2014–2029
- 7.9.1 MEA Alcohol Addiction Therapeutics Share by Region
- 7.9.2 MEA Alcohol Addiction Therapeutics Market Share by Type
- 7.9.3 MEA Alcohol Addiction Therapeutics Share by End User
- 7.1 MEA Alcohol Addiction Therapeutics Market by Type
- Chapter 8 Global Alcohol Addiction Therapeutics Market Company Profiles
- 8.1 Market Competition Scenario Analysis, By Company
- 8.2 Overview of Major Market Players
- 8.2.1 Cipla Limited
- 8.2.1.1 Company Overview
- 8.2.1.2 Business Description
- 8.2.1.3 Product Portfolio
- 8.2.1.4 Key Financials
- 8.2.1.5 Key Developments
- 8.2.1.6 SWOT Analysis
- 8.2.2 GlaxoSmithKline plc
- 8.2.2.1 Company Overview
- 8.2.2.2 Business Description
- 8.2.2.3 Product Portfolio
- 8.2.2.4 Key Financials
- 8.2.2.5 Key Developments
- 8.2.2.6 SWOT Analysis
- 8.2.3 Henry Schein, Inc.
- 8.2.3.1 Company Overview
- 8.2.3.2 Business Description
- 8.2.3.3 Product Portfolio
- 8.2.3.4 Key Financials
- 8.2.3.5 Key Developments
- 8.2.3.6 SWOT Analysis
- 8.2.4 Merck & Co., Inc.
- 8.2.4.1 Company Overview
- 8.2.4.2 Business Description
- 8.2.4.3 Product Portfolio
- 8.2.4.4 Key financials
- 8.2.4.5 Key Developments
- 8.2.4.6 SWOT Analysis
- 8.2.5 Sun Pharmaceutical Industries Ltd.
- 8.2.5.1 Company overview
- 8.2.5.2 Business Description
- 8.2.5.3 Product Portfolio
- 8.2.5.4 Key Financials
- 8.2.5.5 Key Developments
- 8.2.5.6 SWOT Analysis
- 8.2.6 Mallinckrodt Pharmaceuticals
- 8.2.6.1 Company Overview
- 8.2.6.2 Business Description
- 8.2.6.3 Key Financials
- 8.2.6.4 Key Developments
- 8.2.6.5 SWOT Analysis
- 8.2.7 Teva Pharmaceutical Industries Ltd
- 8.2.7.1 Company Overview
- 8.2.7.2 Business Description
- 8.2.7.3 Product Portfolio
- 8.2.7.4 Key Financials
- 8.2.7.5 Key Developments
- 8.2.7.6 SWOT Analysis
- 8.2.8 Mylan (Apicore US LLC)
- 8.2.8.1 Company Overview
- 8.2.8.2 Business Description
- 8.2.8.3 Product Portfolio (Apicore US LLC)
- 8.2.8.4 Key Financials
- 8.2.8.5 Key Developments
- 8.2.8.6 SWOT Analysis
- 8.2.9 Noramco GmbH
- 8.2.9.1 Company Overview
- 8.2.9.2 Business Description
- 8.2.9.3 Product Portfolio
- 8.2.9.4 Key Developments
- 8.2.10 Kinnov-Therapeutics
- 8.2.10.1 Company Overview
- 8.2.10.2 Business Description
- 8.2.10.3 Product Portfolio
- 8.2.10.4 Key Developments
- 8.2.11 Chronos Therapeutics Limited
- 8.2.11.1 Company Overview
- 8.2.11.2 Business Description
- 8.2.11.3 Product Portfolio
- 8.2.11.4 Key Developments
- 8.2.12 Bionex Pharmaceuticals LLC
- 8.2.12.1 Company Overview
- 8.2.12.2 Business Description
- 8.2.12.3 Product Portfolio
- 8.2.13 Curemark LLC
- 8.2.13.1 Company Overview
- 8.2.13.2 Business Description
- 8.2.13.3 Product Portfolio
- 8.2.13.4 Key Developments
- 8.2.1 Cipla Limited
- Chapter 9 Research Methodology
- 9.1 Research Methodology
- 9.2 Primary Research
- 9.3 Secondary Research
- 9.4 Report Scope
- Chapter 10 About Us
- 10.1 Who we are:
- Chapter 11 Disclaimer
- Chapter 1 Global Alcohol Addiction Therapeutics Market Insights
-
- Cipla Limited
- GlaxoSmithKline plc
- Henry Schein, Inc.
- Merck & Co. Inc.
- Sun Pharmaceutical Industries Ltd
- Mallinckrodt Pharmaceuticals
- Teva Pharmaceutical Industries Ltd.
- Mylan (Apicore US LLC)
- Noramco GmbH
- Kinnov-Therapeutics
- Chronos Therapeutics Limited
- Bionex Pharmaceuticals LLC
- Curemark LLC